Research field (1):
Tumor diagnostics and therapeutics
Research theme for competitive and other funds (2):
2023 - 2026 術前ウイルス療法による長期抗腫瘍免疫賦活を介した術後免疫療法効果増強の検討
2020 - 2022 the superiority of the p53 overexpressing oncolytic adenovirus mediated tumor-specific to chemotherapies in immunotherapy for a pancreatic cancer
Papers (85):
Kazuya Moriwake, Kazuhiro Noma, Kento Kawasaki, Tasuku Matsumoto, Masashi Hashimoto, Takuya Kato, Naoaki Maeda, Shunsuke Tanabe, Yasuhiro Shirakawa, Toshiyoshi Fujiwara. Subtotal esophagectomy and concurrent reconstruction with free jejunal flap for primary esophageal cancer after pancreatoduodenectomy. Surgical case reports. 2024. 10. 1. 128-128
Masashi Hashimoto, Shinji Kuroda, Nobuhiko Kanaya, Daisuke Kadowaki, Yusuke Yoshida, Masaki Sakamoto, Yuki Hamada, Ryoma Sugimoto, Chiaki Yagi, Tomoko Ohtani, et al. Long-term activation of anti-tumor immunity in pancreatic cancer by a p53-expressing telomerase-specific oncolytic adenovirus. British Journal of Cancer. 2024